Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eosinophilic Asthma”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Testing effectiveness (Phase 2)Study completedNCT04674137
What this trial is testing

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

Who this might be right for
Bronchial AsthmaEosinophilic Asthma
Chemlmmune Therapeutics LLC 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT07444567
What this trial is testing

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Who this might be right for
AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
AstraZeneca 230
Not applicableUnknownNCT04512521
What this trial is testing

Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Hannover Medical School 40
Post-approval studies (Phase 4)Active Not RecruitingNCT03953300
What this trial is testing

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

Who this might be right for
Asthma
AstraZeneca 75
Post-approval studies (Phase 4)Study completedNCT01171365
What this trial is testing

Small Particle Steroids in Refractory Asthma

Who this might be right for
Asthma
University of Nottingham 30
Not applicableUnknownNCT05139381
What this trial is testing

Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab

Who this might be right for
Asthma in Children
King's College Hospital NHS Trust 148
Not applicableStudy completedNCT05603845
What this trial is testing

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

Who this might be right for
Severe Asthma
AstraZeneca 291
Large-scale testing (Phase 3)Ended earlyNCT04049175
What this trial is testing

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Chiesi Farmaceutici S.p.A. 810
Testing effectiveness (Phase 2)Active Not RecruitingNCT06680947
What this trial is testing

A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 225
Not applicableStudy completedNCT05091385
What this trial is testing

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Who this might be right for
Asthma; Eosinophilic
Medical University of Lodz 106
Large-scale testing (Phase 3)Study completedNCT05243680
What this trial is testing

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Who this might be right for
Asthma
GlaxoSmithKline 641
Post-approval studies (Phase 4)Study completedNCT04710134
What this trial is testing

Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

Who this might be right for
Asthma; Eosinophilic
McMaster University 10
Testing effectiveness (Phase 2)UnknownNCT03010436
What this trial is testing

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Who this might be right for
Asthma
National Jewish Health 10
Testing effectiveness (Phase 2)Study completedNCT03469934
What this trial is testing

Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
AnaptysBio, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02377427
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

Who this might be right for
Asthma
GlaxoSmithKline 36
Testing effectiveness (Phase 2)Study completedNCT03858686
What this trial is testing

The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.

Who this might be right for
Asthma, COPD
Foresee Pharmaceuticals Co., Ltd. 27
Large-scale testing (Phase 3)Ended earlyNCT03052725
What this trial is testing

Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Who this might be right for
Eosinophils, Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 391
Large-scale testing (Phase 3)Study completedNCT04281108
What this trial is testing

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

Who this might be right for
Eosinophilic Esophagitis
Ellodi Pharmaceuticals, LP 143
Post-approval studies (Phase 4)Study completedNCT04276233
What this trial is testing

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Who this might be right for
Asthma
GlaxoSmithKline 100
Not applicableNo Longer AvailableNCT05095116
What this trial is testing

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

Who this might be right for
Eosinophilic Esophagitis
Ellodi Pharmaceuticals, LP
Load More Results